Walter Ferdinand Maria Filliers
Inventor
Stats
- 9 US patents issued
- 12 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 9 US Patents Issued
- 12 US Applications Filed
- 18 Total Citation Count
- May 8, 2017 Most Recent Filing
- Sep 8, 2003 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| MITSUBISHI TANABE PHARMA CORPORATION | 1
| 2009
|
| JANSSEN PHARMACEUTICA NV | 1
6 1 2 1 1 | 2003
2005 2007 2008 2009 2012 |
| JANSSEN PHARMACEUTICA NA | 2
| 2007
|
| RESPIVERT LIMITED | 3
1 | 2013
2017 |
Inventor Addresses
| Address | Duration |
|---|---|
| Beerse, BE | Jan 18, 05 - Aug 24, 17 |
| Vremde, BE | May 31, 07 - Jun 16, 15 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 4 |
| C07C: | ACYCLIC OR CARBOCYCLIC COMPOUNDS | 2 |
| C07D: | HETEROCYCLIC COMPOUNDS | 8 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2017/0239,256 | 2017 | CRYSTALLINE Pl3 KINASE INHIBITORS | 0 |
| 9642799 | 2017 | Crystalline 6-(2-((4-amino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-D]pyrimidin-1-yl)methyl)-3-(2-chlorobenzyl)-4-0X0-3,4-dihydroquinazolin-5-yl)-N,N-bis(2-methoxyethyl)hex-5-ynamide | 1 |
| 9056850 | 2015 | Process for the preparation of compounds useful as inhibitors of SGLT | 0 |
| 2015/0105,408 | 2015 | CRYSTALLINE Pl3 KINASE INHIBITORS | 0 |
| 2015/0099,768 | 2015 | NOVEL PHARMACEUTICAL FORMULATIONS | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.